Home / Recalls / Genentech Inc / D-088-2013

D-088-2013 Class II Terminated

Recalled by Genentech Inc — South San Francisco, CA

Recall Details

Product Type
Drugs
Report Date
December 12, 2012
Initiation Date
September 20, 2012
Termination Date
December 24, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,791 syringes

Product Description

Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0074-01

Reason for Recall

Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).

Distribution Pattern

Nationwide

Code Information

Lot # 936670 Exp. 09/30/13

Other recalls by Genentech Inc

  • D-0509-2024 Class II — Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Fran (May 20, 2024)
  • D-0025-2023 Class III — Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing (October 18, 2022)
  • D-0650-2021 Class II — Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Su (June 9, 2021)
  • D-0357-2021 Class III — Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volum (April 20, 2021)
  • D-0416-2018 Class III — Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, (February 5, 2018)
  • D-1175-2017 Class I — Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 (September 5, 2017)
  • D-0648-2017 Class II — Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzer (March 13, 2017)
  • D-097-2013 Class III — CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count (September 27, 2012)
  • D-087-2013 Class II — Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, (September 20, 2012)
  • D-135-2013 Class I — Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL (July 30, 2012)